LENSAI
LIVE

Serial Number

79408263

Owner

Biostrand

Attorney

Clifford D. Hyra

Filing Date

May 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LENSAI Trademark

Serial Number: 79408263 • Registration: 7954131

LENSAI is a trademark filed by Biostrand on May 13, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Biostrand

Agoralaan A bis

Entity Type: 98

Trademark Details

Filing Date

May 13, 2024

Registration Date

September 23, 2025

Published for Opposition

August 5, 2025

Goods & Services

Downloadable and recorded software for the analysis of biological samples, genetical, protein or sequence related data; downloadable and recorded software relating to the biological, biotechnological, pharmaceutical, medical, veterinary, agricultural, and food technology research fields for the analysis of biological samples, genetical, protein or sequence related data; downloadable and recorded software for the characterization of biopolymers, biological samples and biological particles; scientific research and laboratory apparatus for the analysis of biological samples, genetical, protein or sequence related data, namely, laboratory devices for detecting genetic sequences and corresponding downloadable and recorded operating system software; laboratory apparatus and instruments for the analysis of biological samples, genetical, protein or sequence related data, namely, biological microscopes and corresponding downloadable and recorded operating system software; biometric identification apparatus for laboratory purposes, namely, biometric scanners, and corresponding downloadable and recorded operating system software; downloadable cloud-based software for storing and managing electronic data in the field of biological sequence data and data linked thereto; downloadable cloud-based software for structuring, clustering, manipulating, processing and ranking data relating to the biological, biotechnological, pharmaceutical and medical research field; downloadable cloud-based software for the analysis of biological samples, genetic, protein and sequence related data; downloadable cloud-based software, for the characterization of biopolymers, biological samples and biological particles; scientific research and laboratory apparatus, namely, DNA, RNA and protein sequencers and corresponding recorded operating system software sold as a unit; devices, namely, DNA, RNA and protein sequencers for analyzing biological samples, genetical, protein or sequence related data used as scientific laboratory apparatus and related downloadable operating system software; diagnostic apparatus for biological research and laboratory use, namely, DNA, RNA and protein sequencers and downloadable operating system software sold as a unit; instruments for scientific laboratory use, namely, DNA, RNA and protein sequencers and downloadable operating system software sold as a unit

Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based software program to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling; biological research laboratory services; biological research and analysis, and development of biological samples, genetical, protein or sequence related data for medical use; biological research laboratory services, namely, sequencing of biological samples, including DNA and RNA and analysis thereof; biological research, development and analysis of biological samples, including DNA and RNA; biological research, namely, identification and characterization of biopolymers, biological samples, biological sequences and biological particles; scientific and technological services, namely, scientific research, analysis and testing in the field of biology, biotechnology, genetics, pharmacy and medicine; biological research and analysis, and development of biotechnology; biological analysis of biological samples, genetical, protein or sequence related data for medical use; Software-as-a-service (SAAS) services featuring software to perform genetic research and analysis by applying algorithmic principles for quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling

Medical apparatus and instruments for use in biological, biotechnological, pharmaceutical and medical fields, namely, medical diagnostic apparatus for testing DNA, RNA and protein samples for medical and veterinary diagnostics, examination and monitoring of biological samples, genetical, protein or sequence related data; medical apparatus and instruments for testing DNA, RNA and protein samples, namely, DNA, RNA and protein sequencers to identify the microbiological makeup and profile of a subject for medical diagnostic purposes; medical apparatus and instruments for testing DNA, RNA and protein samples, namely, DNA, RNA and protein sequencers for the characterization of biopolymers, biological samples and biological particles for medical diagnostic purposes; apparatus for analyzing biological samples, genetical, protein or sequence related data for medical use, namely, DNA, RNA and protein sequencers for testing DNA, RNA and protein samples for medical diagnostic purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 2, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 2, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 23, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2025 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Feb 28, 2025 NREP
REFUSAL PROCESSED BY IB
Jan 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 28, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 27, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 4, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2024 REPR